How can natural language processing help model informed drug development?: a review
Citation: Roopal Bhatnagar, Sakshi Sardar, Maedeh Beheshti, Jagdeep T Podichetty, JAMIA Open, Volume 5, Issue 2, July 2022, ooac043
Related Posts
-
C-Path Appoints Key Scientific Leaders to Executive Roles -
Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies -
eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain -
Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP) best practices and recommendations for FAIR data, toward alignment with International Regulatory agencies
-
Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data